Glimikem-M2 Sr Tablet (Glimepiride 2 mg + Metformin 500 mg)

Composition (per tablet):

Glimepiride 2 mg

Metformin Hydrochloride (Sustained Release) 500 mg
Manufacturer: Alkem Laboratories Ltd.

Description:

Glimikem-M2 SR Tablet is an oral antidiabetic combination of Glimepiride and Metformin (Sustained Release) used in the treatment of Type 2 Diabetes Mellitus (T2DM).
The combination provides dual glycemic control by stimulating insulin secretion and improving insulin sensitivity, ensuring effective management of blood glucose levels throughout the day..

Warnings & Precautions:

Regular monitoring of blood glucose and HbA1c is essential.

Periodic renal and hepatic function tests recommended.

Use cautiously in elderly, malnourished, or physically weak patients.

Avoid alcohol consumption (risk of lactic acidosis).

Discontinue before contrast radiography or major surgical procedures.

Adverse Effects:

Common: Hypoglycemia, nausea, diarrhea, abdominal discomfort, dizziness.

Less common: Headache, mild rash, metallic taste.

Rare: Lactic acidosis, hepatic dysfunction, allergic reactions.

Storage:

Store below 25°C, protected from light and moisture.
Keep out of reach of children.